Dysautonomia and its underlying mechanisms in the hypermobility type of Ehlers-Danlos syndrome

Seminars in Arthritis and Rheumatism

Volumn 44, Issue 1, 2014, Pages 93-100

  De Wandele, Inge ^a   Rombaut, Lies ^a   Leybaert, Luc ^a   Van de Borne, Philippe ^b   De Backer, Tine ^c   Malfait, Fransiska ^d   De Paepe, Anne ^d   Calders, Patrick ^a  

^a GHENT UNIVERSITY   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Autonomic dysfunction; Ehlers Danlos syndrome; Hypermobility; Orthostatic intolerance

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; LOSARTAN; MELITRACEN; MORPHINE; OXYCODONE; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT;

ADRENERGIC ACTIVITY; ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVOUS SYSTEM; CONNECTIVE TISSUE; CONTROLLED STUDY; DEPRESSION; DEREGULATION; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DYSAUTONOMIA; EHLERS DANLOS SYNDROME; FEMALE; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHY; ORTHOSTATIC HYPOTENSION; ORTHOSTATIC INTOLERANCE; PHYSICAL ACTIVITY; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PRESSORECEPTOR REFLEX; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RESTING HEART RATE; SCORING SYSTEM; SENSITIVITY ANALYSIS; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; VALSALVA MANEUVER; BLOOD PRESSURE; COMPLICATION; HEART RATE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; BLOOD PRESSURE; EHLERS-DANLOS SYNDROME; FEMALE; HEART RATE; HUMANS; MIDDLE AGED; PRIMARY DYSAUTONOMIAS; QUESTIONNAIRES;

EID: 84905282385     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2013.12.006     Document Type: Article

References (49)

1. Beighton P., De Paepe A., Steinmann B., Tsipouras P., Wenstrup R.J. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 1998, 77:31-37.
2. Levy H.P. Ehlers-Danlos syndrome, hypermobility type. Gene Reviews 1993, University of Washington, Seattle, Seattle, WA. R.A. Pagon, M.P. Adam, T.D. Bird, C.R. Dolan, C.T. Fong, K. Stephens (Eds.).
3. Rombaut L., Malfait F., Cools A., De Paepe A., Calders P. Musculoskeletal complaints, physical activity and health-related quality of life among patients with the Ehlers-Danlos syndrome hypermobility type. Disabil Rehabil 2010, 32:1339-1345.
4. Castori M., Camerota F., Celletti C., Danese C., Santilli V., Saraceni V.M., et al. Natural history and manifestations of the hypermobility type Ehlers-Danlos syndrome: a pilot study on 21 patients. Am J Med Genet A 2010, 152A:556-564.
5. De Wandele I., Rombaut L., Malfait F., De Backer T., De Paepe A., Calders P. Clinical heterogeneity in patients with the hypermobility type of Ehlers-Danlos syndrome. Res Dev Disabil 2013, 34:873-881.
6. Gazit Y., Nahir A.M., Grahame R., Jacob G. Dysautonomia in the joint hypermobility syndrome. Am J Med 2003, 115:33-40.
7. Martinez-Lavin M., Hermosillo A.G. Autonomic nervous system dysfunction may explain the multisystem features of fibromyalgia. Semin Arthritis Rheum 2000, 29:197-199.
8. Freeman R. The chronic fatigue syndrome is a disease of the autonomic nervous system. Sometimes. Clin Auton Res 2002, 12:231-233.
9. van Dijk N., Boer M.C., Mulder B.J., van Montfrans G.A., Wieling W. Is fatigue in Marfan syndrome related to orthostatic intolerance?. Clin Auton Res 2008, 18:187-193.
10. Singer D.H., Martin G.J., Magid N., Weiss J.S., Schaad J.W., Kehoe R., et al. Low heart rate variability and sudden cardiac death. J Electrocardiol 1988, 21(Suppl):S46-S55.
11. Fedorowski A., Melander O. Syndromes of orthostatic intolerance: a hidden danger. J Intern Med 2013, 273:322-335.
12. Schwartz P.J., La Rovere M.T., Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 1992, 85(Suppl. 1):I77-I91.
13. Benrud-Larson L.M., Dewar M.S., Sandroni P., Rummans T.A., Haythornthwaite J.A., Low P.A. Quality of life in patients with postural tachycardia syndrome. Mayo Clin Proc 2002, 77:531-537.
14. Low PAaB Quality of life in dysautonomia. Clinical Autonomic Disorders 2010, 179-184. Lippincott Williams & Wiklins Rochester. 3rd ed. P.A. Low (Ed.).
15. Mustafa H.I., Fessel J.P., Barwise J., Shannon J.R., Raj S.R., Diedrich A., et al. Dysautonomia: perioperative implications. Anesthesiology 2012, 116:205-215.
16. Kernan S., Tobias J.D. Perioperative care of an adolescent with postural orthostatic tachycardia syndrome. Saudi J Anaesth 2010, 4:23-27.
17. Rombaut L., Malfait F., De Wandele I., Cools A., Thijs Y., De Paepe A., et al. Medication, surgery, and physiotherapy among patients with the hypermobility type of Ehlers-Danlos syndrome. Arch Phys Med Rehabil 2011, 92:1106-1112.
18. Rowe P.C., Barron D.F., Calkins H., Maumenee I.H., Tong P.Y., Geraghty M.T. Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome. J Pediatr 1999, 135:494-499.
19. Benarroch E.E. Postural tachycardia syndrome: a heterogeneous and multifactorial disorder. Mayo Clin Proc 2012, 87:1214-1225.
20. Boardman A., Schlindwein F.S., Rocha A.P., Leite A. A study on the optimum order of autoregressive models for heart rate variability. Physiol Meas 2002, 23:325-336.
21. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996, 17:354-381.
22. Rudas L., Crossman A.A., Morillo C.A., Halliwill J.R., Tahvanainen K.U., Kuusela T.A., et al. Human sympathetic and vagal baroreflex responses to sequential nitroprusside and phenylephrine. Am J Physiol 1999, 276(5 Pt 2):H1691-H1698.
23. Westerhof B.E., Gisolf J., Stok W.J., Wesseling K.H., Karemaker J.M. Time-domain cross-correlation baroreflex sensitivity: performance on the EUROBAVAR data set. J Hypertens 2004, 22:1371-1380.
24. Novak P. Quantitative autonomic testing. J Vis Exp 2011, 53. [pii: 2502. doi: 10.3791/2502].
25. Schrezenmaier C., Singer W., Swift N.M., Sletten D., Tanabe J., Low P.A. Adrenergic and vagal baroreflex sensitivity in autonomic failure. Arch Neurol 2007, 64:381-386.
26. Freeman R., Wieling W., Axelrod F.B., Benditt D.G., Benarroch E., Biaggioni I., et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci 2011, 161:46-48.
27. Wieling W., Schatz I.J. The consensus statement on the definition of orthostatic hypotension: a revisit after 13 years. J Hypertens 2009, 27:935-938.
28. Low P.A.S., Sandroni P., Joyner M.J., Shen W.K. Postural tachycardia syndrome. Clinical Autonomic Disorders 2010, 515-533. Lippincott Williams & Wiklins Rochester. 3rd ed. P.A. Low (Ed.).
29. Fessel J., Robertson D. Orthostatic hypertension: when pressor reflexes overcompensate. Nat Clin Pract Nephrol 2006, 2:424-431.
30. Schrezenmaier C., Gehrking J.A., Hines S.M., Low P.A., Benrud-Larson L.M., Sandroni P. Evaluation of orthostatic hypotension: relationship of a new self-report instrument to laboratory-based measures. Mayo Clin Proc 2005, 80:330-334.
31. Juul-Kristensen B., Rogind H., Jensen D.V., Remvig L. Inter-examiner reproducibility of tests and criteria for generalized joint hypermobility and benign joint hypermobility syndrome. Rheumatology 2007, 46:1835-1841.
32. Remvig L., Duhn P., Ullman S., Arokoski J., Jurvelin J., Safi A., et al. Skin signs in Ehlers-Danlos syndrome: clinical tests and para-clinical methods. Scand J Rheumatol 2010, 39:511-517.
33. Baecke J.A., Burema J., Frijters J.E. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982, 36:936-942.
34. Snaith R.P. The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes 2003, 1:29.
35. Freynhagen R., Baron R., Gockel U., Tolle T.R. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006, 22:1911-1920.
36. Low PAaS D.M. Laboratory evaluation of the autonomic nervous system. Clinical Autonomic Disorders 2010, 143. Lippincott Williams & Wiklins, Rochester. 3rd ed. P.A. Low (Ed.).
37. Martinez-Lavin M. Biology and therapy of fibromyalgia. Stress, the stress response system, and fibromyalgia. Arthritis Res Ther 2007, 9:216.
38. van de, Borne P., Montano N., Pagani M., Oren R., Somers V.K. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation 1997, 95:1449-1454.
39. Cohen H., Neumann L., Shore M., Amir M., Cassuto Y., Buskila D. Autonomic dysfunction in patients with fibromyalgia: application of power spectral analysis of heart rate variability. Semin Arthritis Rheum 2000, 29:217-227.
40. Grubb B.P., Kanjwal M.Y., Kosinski D.J. Review: the postural orthostatic tachycardia syndrome: current concepts in pathophysiology diagnosis and management. J Interv Card Electrophysiol 2001, 5:9-16.
41. Voermans N.C., Drost G., van Kampen A., Gabreels-Festen A.A., Lammens M., Hamel B.C., et al. Recurrent neuropathy associated with Ehlers-Danlos syndrome. J Neurol 2006, 253:670-671.
42. Kanjwal Y., Kosinski D., Grubb B.P. The postural orthostatic tachycardia syndrome: definitions, diagnosis, and management. Pacing Clin Electrophysiol 2003, 26:1747-1757.
43. Raj S.R. The postural tachycardia syndrome (POTS): pathophysiology, diagnosis & management. Indian Pacing Electrophysiol J 2006, 6:84-99.
44. Mathias C.J., Low D.A., Iodice V., Owens A.P., Kirbis M., Grahame R. Postural tachycardia syndrome-current experience and concepts. Nat Rev Neurol 2012, 8:22-34.
45. Bradley J.G., Davis K.A. Orthostatic hypotension. Am Fam Physician 2003, 68:2393-2398.
46. Milazzo V., Di Stefano C., Servo S., Crudo V., Fulcheri C., Maule S., et al. Drugs and Orthostatic hypotension: evidence from the literature. J Hypertens 2012, 1:104.
47. Hausberg M., Hillebrand U., Kisters K. Addressing sympathetic overactivity in major depressive disorder. J Hypertens 2007, 25:2004-2005.
48. Rahman A., Holman J.A. Fibromyalgia and hypermobility. Hypermobility, Fibromyalgia and Chronic Pain 2010, 61-68. Elsevier. 1st ed. A.J. Hakim, R. Keer, R. Grahame (Eds.).
49. Nahm F., Freeman R. Autonomic testing. The Clinical Neurophysiology Primer 2007, 447-460. Humana Press Totowa, New Jersey. 1st ed. A.S. Blum (Ed.).